A Retrospective Cohort Study of Racial/Ethnic and Socioeconomic Disparities in Initiation and Meaningful Use of Continuous Glucose Monitoring Among Youth With Type 1 Diabetes
Main finding · CGM start, use-days and discontinuation by insuranceResult — go to the resultHazard ratio 1.61Authors' conclusion
Given the impact of insurance and race/ethnicity on CGM initiation and use, it is imperative that we target interventions to support universal access and sustained CGM use to mitigate the potential impact of provider biases and systemic disadvantage and racism. By enabling more equitable and meaningful T1D technology use, such interventions will begin to alleviate outcome disparities between youth with T1D from different backgrounds.
Study context
- Population
- Youth with T1D from a pediatric T1D program, followed 1 year from diagnosis (2016–2020) or continuous glucose monitor (CGM) uptake (2015–2020)cohorts n = 815 and n = 1392
- Exposure
- Public vs private insurance; Hispanic and black vs white
- Outcome
- CGM start and meaningful use (median days, 1-year proportions, survival analysis)
- Follow-up
- One year
Methodological detailstwo cohorts, single pediatric T1D program
- Two cohorts
- Single pediatric T1D program
Main finding
As reported in the abstract
Hazard ratio
1.61
P < 0.001
Observational data: associations, not effects.
Further findings
Time to CGM start by race/ethnicity — Hispanic vs White · P across Hispanic, black and white
P = 0.0013
| Outcome | HR | P value |
|---|---|---|
| CGM discontinuation by race/ethnicityHispanic vs White | 2.17 | P < 0.001 |
| CGM discontinuation by race/ethnicityBlack vs White | 1.45 | P = 0.038 |
| CGM discontinuation among privately insured, Hispanic/black vs white | 1.44 | P = 0.0286 |
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →